New Randomized Study Shows 3.15% Chlorhexidine Gluconate/70% Isopropyl Alcohol Solution Most Effective for Disinfecting Needleless Access Sites at 5 Second Scrub Time

October 24th, 2014

PDI Prevantics® Device Swab is the only 3.15% Chlorhexidine Gluconate/70% alcohol solution to receive market authorization by the FDA

Clinical investigators recently released results from the first and only randomized, cross-over, prospective, comparative effectiveness clinical study evaluating the benefits of a 3.15% Chlorhexidine Gluconate (CHG) and 70% Isopropyl Alcohol over 70% Isopropyl Alcohol alone in disinfecting needleless connectors. The study was funded by the US Centers for Disease Control and Prevention (CDC) Epicenters Program and executed by Rush University in Chicago, IL. The results were presented at the 2014 IDWeek Conference in Philadelphia, PA, on October 11, 2014.

The findings align with CDC Guidelines which state: “Some studies have shown that disinfection of the devices with chlorhexidine/alcohol solutions appears to be most effective in reducing colonization.” The investigators determined that the CHG and alcohol scrub resulted in less needleless connector contamination than an alcohol scrub at a five second scrub time. Prevantics® Device Swab from PDI, leading provider of infection prevention solutions, is the only 3.15% Chlorhexidine Gluconate and 70% Isopropyl Alcohol solution that has received market authorization from the U.S. Food and Drug Administration (FDA) for disinfecting needleless access sites prior to use.

“This study answers a previously unknown clinical question about the most efficacious antiseptic for disinfection of needleless access sites and also ideal prep times,” said Hudson Garrett, PhD, Vice-President, Clinical Affairs for PDI. “This study demonstrates the importance of targeted efforts to reduce contamination on needleless access sites and ensure evidence-based practices for disinfection of needleless access sites.”

The PDI Prevantics® Device Swab is fully compliant with the evidence-based guidelines and recommendations from the US Centers for Disease Control and Prevention (CDC), the Infusion Nurses Society, the Association for Vascular Access, and the Association for Professionals in Infection Control and Epidemiology.

About PDI

PDI helps reduce preventable infections, control healthcare costs, and ultimately help save lives by delivering a broad range of evidence-based, market leading skin antisepsis, environmental hygiene and patient care solutions. PDI’s expertise in making a difference in the community and healthcare environments extends throughout the United States and worldwide. pdihc.com

Mercury Media Names Andrew McLean Chief Executive Officer Industry Leader Brings Experience and Track Record

September 22nd, 2014

Mercury Media, the largest independent full-service performance media company in the U.S., has named Andrew McLean Chief Executive Officer.  Widely recognized for his leadership of media agencies and client focused operations, McLean brings over 25 years of strategic marketing and media experience to Mercury.

 

“Andrew is the ideal individual to lead our future efforts,” said Maria Eden, President of Mercury Media. “He brings leadership expertise, strategic know-how, excellent client and talent development skills, and deep industry knowledge.”

 

McLean comes to Mercury with over 25 years of media experience gained from working with clients and companies, most recently in the digital and entertainment sides of the business with Inventus Media, Deluxe, and ZONZA. He also served as Chief Executive Officer of Omnicom’s PHD, a media and communications agency. McLean led PHD through a period of dramatic growth and digital expansion.

 

“Success in media is all about service and performance and this is Mercury Media’s DNA. I am delighted to be joining the Mercury team and look forward to helping grow our clients’ business through the increased focus on performance that embodies Mercury Media,” said McLean.

 

McLean is best known for the 12 years he spent at WPP’s MEC and GroupM as part of the original management team who founded and grew GroupM. McLean served in a number of roles including Chief Development Officer where he grew revenue, managed major clients, and developed an executive development program for next generation leadership.  While at GroupM, McLean provided management support to six media companies and worked on the trading team integrating digital and traditional media buying. He started at MEC as part of the senior management team that oversaw the merger of The Media Edge with CIA and built it into one of the most successful and globally recognized media agencies.

 

Earlier in his career, McLean held executive positions at The Walt Disney Company and DMB&B/Mediavest. He is Chairman of the NY Chapter of the International Advertising Association, a member of the Executive Committee of the Grady School of Mass Communication at the University of Georgia, and holds other board positions in the media industry and with non-profit organizations. He is a frequent and well-known industry speaker.

 

About Mercury Media

Founded in 1989, Mercury Media is the largest privately-owned, full service performance marketing agency in the country, with a focus on direct response marketing across multiple channels and formats.  With offices in New York, Los Angeles, Boston, Philadelphia, Princeton and Chicago, Mercury specializes in placing and managing fully integrated advertising campaigns that enable its clients to cost effectively generate transactions and/or acquire customers through the use of television and digital media to both general market and Hispanic media. For more information, please visit http://mercurymedia.com/.





 

 

 

New Survey Says Nurses Are Bullish On The Industry Outlook

August 27th, 2014

A survey from allnurses.com, the largest online networking and support site for nurses, reveals that the majority of nurses (74 percent) think the job outlook for the nursing industry is positive. Nearly three quarters of respondents (72 percent) would recommend that a person go into the nursing field, and the overwhelming majority (82 percent) believe that the nursing industry has a positive perception in society today.

 “There are many misperceptions about nurses, the role they play, and the industry overall,” said Brian Short, Founder of allnurses.com, and a registered nurse himself. “These survey results – which are quite positive – provide a more accurate and up to date look into what nurses think, and indicate areas where patients and nurses can work more closely together.”

Of particular importance, said Short, is the critical role that nurses play in serving as the patient’s advocate. He encourages patients and their families to talk to their nurses as they are the closest to the patient and work hand in hand with doctors to deliver the best and most appropriate care.

Forty percent of nurses said the single biggest challenge they face today is the nurse-to-patient ratio. Nurses want to spend more time at the bedside, but administrative duties and having too many patients can keep them from doing so. Nurses also believe that patients and their families are confused when it comes to knowing the role nurses play vs. that of physicians, with less than 10 percent of nurses thinking that patients understand the difference.

When asked what makes an ideal nurse, respondents ranked knowledgeable, compassionate and patient advocate as the most important characteristics. Gallup polls show that nurses are consistently ranked the highest among other professions for trustworthiness and credibility. When nurses were asked to weigh in on which hospital TV shows most closely resemble “real life,” it was a close race among the long-running ER and Grey’s Anatomy hospital dramas and the more recently launched documentary-style program, NY Med.

More than 1,600 nurses and registered members of allnurses.com completed the survey, with the majority of them (47 percent) working in hospital settings. Recent estimates show that between 2008 and 2010 there were approximately 2.8 million registered nurses (RNs) and 690,000 licensed practical nurses (LPNs) in the United States. Registered nurses are the largest sector of employees in the healthcare industry.

ABOUT ALLNURSES

Founded by Minnesota Registered Nurse, Brian Short, allnurses.com is the leading networking site for nurses and nursing students. For nearly 20 years, allnurses.com has been the collective voice of the nursing community, supporting the profession by providing a place where nurses can network, share, and learn from each other. With an ever-growing community of more than 825,000 registered members, allnurses.com is the go-to place to communicate and discuss nursing, jobs, schools, NCLEX, careers, and so much more. For more information, visit allnurses.com.

PDI Prevantics® Skin Antiseptics: Proven to Help Facilities Reduce CLABSI Rates and Associated Costs

August 26th, 2014

New educational resources now make it even easier for facilities to implement and encourage ongoing compliance with Prevantics® products.

PDI, leader in infection prevention products and solutions, continues to reinforce the importance of a complete infection prevention program for skin antisepsis. Prevantics® products are the first and only 3.15% Chlorhexidine Gluconate (w/v) and 70% Isopropyl Alcohol (v/v) formula which has been proven to deliver seven days of continued antimicrobial activity, aligning with dressing change protocols at many healthcare facilities. The clinical efficacy of Prevantics® products are supported by more than 14 independent clinical studies, covering both adult and pediatric populations and spanning several practice areas. One medical center demonstrated a 59 percent reduction in central line-associated bloodstream infections (CLABSIs) in the first year after improving practice in infection prevention and vascular access, coupled with the introduction of Prevantics® products to the practice bundle. A 100 percent reduction was achieved by year four.

“Our clinical partners have come to know and expect high-quality, efficacious products from PDI that provide the most advanced evidence-based solutions to prevent the spread of infection and exceed all clinical guidelines requirements,” said Hudson Garrett, PhD, MSN, MPH, FNP, CSRN™, VA-BC™, Vice-President, Clinical Affairs for PDI. “Prevantics® products are no exception, and our continual innovation in formulation and delivery systems has produced excellent and sustained results.”

PDI also continues to provide support tools and clinical resources to help with implementation and on-going compliance to facility and evidence-based protocols. Most recently, the company released new educational and training videos for Prevantics® products to help ensure proper use. The videos can be used for staff education during new hire orientation, product implementation and periodic refreshers. In addition, instructions for use posters and product guides are also available for the product.

Prevantics® products are available in three sizes to accommodate varying types of procedures; 1.0 mL Swab, 1.6 mL Swabstick and 5.1 mL Maxi-Swabstick. The peel-apart packaging and unique pre-saturated applicator design make it easy to use. It contains no glass to break and does not require any activation wait time by the clinician. The Prevantics® products Swabstick and Maxi Swabstick also feature unique two-sided applicators designed for prepping around joints, inter-digital areas and skin folds. The company recently updated the product packaging with a cleaner and simpler look aimed at helping staff to easily identify the product. For more information on Prevantics® products or to access the new in-service videos, visit www.pdihc.com or contact your local PDI sales representative.

Prevantics® products meet guidelines from leading regulatory agencies and industry associations such as the US Centers for Disease Control and Prevention (CDC), Association for Vascular Access (AVA), Infusion Nurses Society (INS), Society for Healthcare Epidemiology of America (SHEA), Infectious Disease Society of America (IDSA), and Association for Professionals in Infection Control and Epidemiology (APIC). Current CDC Guidelines for the Prevention of Intravascular Catheter-Related Infections recommend the use of a > 0.5% chlorhexidine skin preparation with alcohol for antisepsis.

About PDI
PDI helps reduce preventable infections, control healthcare costs, and ultimately help save lives by delivering a broad range of evidence-based, market leading skin antisepsis, environmental hygiene and patient care solutions. PDI’s expertise in making a difference in the community and healthcare environments extends throughout the United States and worldwide. www.pdihc.com

T&M Associates opens Indianapolis Office Offers Deep Environmental, Health and Safety Management Expertise

August 20th, 2014

T&M Associates, a leading national engineering, environmental services and consulting firm, announces the opening of its Indianapolis office. T&M has appointed Ashly Insco, regional compliance manager and group manager, and Jim Alvarez, client manager and principal geologist, to lead the office. Both are recognized experts in the field and will direct and deliver the company’s broad range of services to public and private sector clients throughout the region. Ms. Insco joins T&M as a certified hazardous materials manager (CHMM) and Mr. Alvarez is a licensed professional geologist (LPG) in the state of Indiana.

Ms. Insco brings more than 22 years of environmental, health and safety (EHS) experience to T&M. She specializes in developing, implementing and auditing EHS and energy management and compliance systems. Ms. Insco also develops and provides customized EHS training for all industries. Mr. Alvarez has particular expertise in developing and administering EHS programs at industrial facilities as well as leading due diligence portfolios, both of which he has conducted globally over the course of his nearly 25-year career.

“While our Indianapolis office is brand new, Ashly and Jim are well established leaders in their sectors and their reputation in the marketplace aligns with T&M’s growth initiatives,” said Ihsan Al-Fayyomi, senior vice president and environmental services business unit leader. “They and their team will deliver the services and expertise to our mid-western client-base while supporting T&M’s strategic capabilities nationwide.”

The new office is located at 201 North Illinois Street, Indianapolis, IN 46204. As part of T&M Associates, it will provide the firm’s full portfolio of services which includes EHS auditing and program development/implementation, site investigation and remediation, due diligence and transactional support, industrial hygiene, permitting, grants and funding, landscape architecture, energy efficiency, transportation engineering, water resources, stormwater management and construction administration among others.

About T&M Associates

T&M Associates is an engineering consulting firm specializing in development, energy, environmental and transportation services. Established in 1966 and headquartered in Middletown, NJ, the award-winning company is consistently ranked in the top half of Engineering News Record’s list of the Top 500 Design Firms. T&M’s tagline, “Your Goals. Our Mission” encapsulates its commitment to develop effective, creative and timely strategies and solutions to achieve its public and private clients’ business objectives. T&M has more than 350 employees and operates in 15 office locations throughout Delaware, Indiana, Kentucky, Massachusetts, New Jersey, Pennsylvania, and Ohio. For more information visit http://www.tandmassociates.com/.